11.03.2022 18:11 | HIK | Transaction in Own Shares | RNS |
10.03.2022 17:48 | HIK | Transaction in Own Shares | RNS |
10.03.2022 16:10 | TRI, TET, SPT | UK dividends calendar - next 7 days | Alliance |
09.03.2022 17:53 | HIK | Transaction in Own Shares | RNS |
08.03.2022 17:21 | HIK | Transaction in Own Shares | RNS |
08.03.2022 10:21 | HIK | Holding(s) in Company | RNS |
07.03.2022 17:12 | HIK | Transaction in Own Shares | RNS |
07.03.2022 13:36 | HIK | Director/PDMR Shareholding | RNS |
04.03.2022 18:20 | HIK | Transaction in Own Shares | RNS |
03.03.2022 17:44 | HIK | Transaction in Own Shares | RNS |
03.03.2022 14:44 | HIK | Director/PDMR Shareholding | RNS |
03.03.2022 10:02 | MTRO, JET, PDL | LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail | Alliance |
03.03.2022 08:28 | LSEG, SDR, CCH | LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule | Alliance |
02.03.2022 18:18 | HIK | Transaction in Own Shares | RNS |
02.03.2022 09:52 | SNR, TPK, XPP | LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail | Alliance |
01.03.2022 17:57 | HIK | Transaction in Own Shares | RNS |
28.02.2022 18:37 | HIK | Transaction in Own Shares | RNS |
28.02.2022 17:16 | HIK | Director/PDMR Shareholding | RNS |
25.02.2022 17:58 | HIK | Hikma Share Buyback Programme | RNS |
25.02.2022 09:40 | HIK | IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback | Alliance |
25.02.2022 09:37 | HIK | Director/PDMR Shareholding | RNS |
25.02.2022 08:22 | IAG, FXPO, HIK | LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022 | Alliance |
25.02.2022 07:00 | HIK | Share Buyback Programme | RNS |
24.02.2022 10:31 | HIK | TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout | Alliance |
24.02.2022 07:00 | HIK | Directorate Change | RNS |
24.02.2022 07:00 | HIK | Final Results | RNS |
23.02.2022 09:23 | HIK | Holding(s) in Company | RNS |
17.02.2022 16:08 | SXS, WPP, SRP | UK earnings, trading statements calendar - next 7 days | Alliance |
16.02.2022 11:26 | HIK | Director/PDMR Shareholding | RNS |
11.02.2022 10:17 | HIK | Holding(s) in Company | RNS |
09.02.2022 09:48 | ASC, THG, JET | LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo | Alliance |
08.02.2022 10:17 | HIK | Notice of Results | RNS |
03.02.2022 09:12 | HIK | Hikma completes acquisition of Teligent's Canadian assets | Alliance |
03.02.2022 07:00 | HIK | Hikma completes acquisition of Teligent | RNS |
02.02.2022 10:04 | HIK | Total Voting Rights | RNS |
24.01.2022 12:45 | HIK | Holding(s) in Company | RNS |
17.01.2022 07:00 | HIK | Acquisition | RNS |
12.01.2022 15:22 | HIK | Holding(s) in Company | RNS |
10.01.2022 07:00 | HIK | Hikma Launches 503B Sterile Compounding Business | RNS |
04.01.2022 14:55 | HIK | Total Voting Rights | RNS |
16.12.2021 13:42 | HIK | Holding(s) in Company | RNS |
14.12.2021 14:34 | HIK | Holding(s) in Company | RNS |
09.12.2021 07:00 | HIK | Richter and Hikma sign agreement for denosumab | Reach |
02.12.2021 10:33 | HIK | Holding(s) in Company | RNS |
23.11.2021 09:57 | HIK | Holding(s) in Company | RNS |
17.11.2021 10:35 | HIK | Holding(s) in Company | RNS |
04.11.2021 07:00 | HIK | Trading Statement | RNS |
01.11.2021 14:06 | HIK | Total Voting Rights | RNS |
04.10.2021 09:55 | HIK | Block listing Interim Review | RNS |
27.09.2021 07:00 | HIK | Hikma acquires Custopharm | RNS |
23.09.2021 07:30 | HIK | Additional Listing | RNS |
06.09.2021 10:42 | HIK | Total Voting Rights | RNS |
27.08.2021 12:15 | HIK | Bio-Thera and Hikma announce exclusive agreement | Reach |
06.08.2021 07:00 | HIK | Half-year Report | RNS |
02.08.2021 14:48 | HIK | Total Voting Rights | RNS |
19.07.2021 09:27 | HIK | Notice of Results | RNS |
05.07.2021 15:43 | HIK | Total Voting Rights | RNS |
02.06.2021 13:14 | HIK | Total Voting Rights | RNS |
17.05.2021 16:00 | HIK | Director/PDMR Shareholding | RNS |
30.04.2021 07:00 | HIK | Hikma announces US FDA approval of KLOXXADO | Reach |
30.04.2021 07:00 | HIK | Trading Statement | RNS |
26.04.2021 11:19 | HIK | Holding(s) in Company | RNS |
23.04.2021 15:51 | HIK | Result of AGM | RNS |
21.04.2021 07:00 | HIK | Hikma resumes launch of generic Advair Diskus® | RNS |
13.04.2021 11:35 | HIK | Block listing Interim Review | RNS |
13.04.2021 09:19 | HIK | Total Voting Rights | RNS |
17.03.2021 14:29 | HIK | Director/PDMR Shareholding | RNS |
17.03.2021 11:08 | HIK | Annual Financial Report | RNS |
15.03.2021 11:24 | HIK | Director/PDMR Shareholding | RNS |
11.03.2021 13:36 | HIK | Hikma and GSK agree to cease potential acquisition | RNS |
02.03.2021 16:44 | HIK | Director/PDMR Shareholding | RNS |
25.02.2021 13:02 | HIK | Director/PDMR Shareholding | RNS |
25.02.2021 13:02 | HIK | Director/PDMR Shareholding | RNS |
25.02.2021 13:01 | HIK | Director/PDMR Shareholding | RNS |
25.02.2021 13:00 | HIK | Director/PDMR Shareholding | RNS |